Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Select Medical Holdings Corporation (SEM) Investigation

NEW YORK, NY / ACCESSWIRE / April 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Select Medical Holdings Corporation ("Select Medical" or "the Company") (NYSE:SEM). Investors who purchased Select Medical securities prior to August 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SEM.

Investigation Details:

The investigation concerns whether Select Medical and certain of its officers and/or directors have engaged in corporate wrongdoing.

What's Next?

If you are aware of any facts relating to this investigation or purchased Select Medical shares, you can assist this investigation by visiting the firm's site: bgandg.com/SEM. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.